Intelligent Bio Solutions Inc. Announces Reverse Stock Split

Core Viewpoint - Intelligent Bio Solutions Inc. will implement a 1-for-10 reverse stock split effective December 15, 2025, to enhance its stock price and maintain compliance with Nasdaq listing requirements [1][2]. Company Overview - Intelligent Bio Solutions Inc. is a medical technology company focused on providing intelligent, rapid, non-invasive testing solutions, particularly through its Intelligent Fingerprinting Drug Screening System [4]. - The company aims to revolutionize portable testing via fingerprint sweat analysis, targeting industries such as construction, manufacturing, transport, and drug treatment organizations [4]. Reverse Stock Split Details - The reverse stock split will combine every 10 shares of common stock into one share, with no fractional shares issued; instead, stockholders will receive cash for any fractional shares [3]. - After the split, the par value of the common stock will remain at $0.01 per share, and the total number of authorized shares will stay at 100 million [3]. - Following the reverse split, approximately 959,533 shares of common stock will be issued and outstanding [3].